FDA是基于其两个随机对照临床试验的结果而认可这个药物的。病例数约为125例，患者至少事先接受过一项针对ITP的治疗。
FDA based its approval on two randomized clinical trials of about 125 patients who had received at least one prior ITP treatment.
FDA是基于其两个随机对照临床试验的结果而认可这个药物的。病例数约为125例，患者至少事先接受过一项针对ITP的治疗。
FDA based its approval on two randomized clinical trials of about 125 patients who had received at least one prior ITP treatment.
应用推荐